Morepen Lab Key Ratios

NSE: MOREPENLAB | BSE: 500288

₹106.19

up-down-arrow9.49 (9.81%)

As on 28-Aug-2026IST

Market cap

info icon

₹5,820 Cr

Revenue (TTM)

info icon

₹1,951 Cr

P/E Ratio

info icon

41.4

P/B Ratio

info icon

4.5

Div. Yield

info icon

0.2 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 17.62 34.07 9.48 8.76 8.17
EBIT 296.70 389.87 29.64 33.58 6.76
Net Profit 258.21 424.80 26.81 35.05 1.65
EPS 258.14 424.62 51.75 40.10 1.29
Book Value -- -- 27.31 22.22 27.29
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info 6.356.717.608.017.40
Net Margin info 4.945.887.136.455.67
Return on equity info 9.9316.159.6111.7812.08
Return on Capital info 13.5718.54--15.4816.82
Return on Assets info 6.428.527.577.698.04
Debt to Equity (x) info ----0.110.070.03
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
--
15.48
16.82
8.40
24.86
Peer Median
--
16.46
15.49
17.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

9.61

Lower than Peers by 0.33

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
9.61
11.78
12.08
5.93
21.79
Peer Median
9.94
13.87
14.72
15.70
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

7.57

Higher than Peers by 0.31

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
7.57
7.69
8.04
3.55
10.55
Peer Median
7.26
8.04
7.19
9.43
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

7.60

Lower than Peers by 1.95

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
7.60
8.01
7.40
3.64
7.05
Peer Median
9.55
10.05
10.28
13.90
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

7.13

Lower than Peers by 1.51

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
7.13
6.45
5.67
2.72
6.49
Peer Median
8.64
9.11
6.78
10.91
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
--
8.11
7.70
4.70
8.36
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

9.48

Higher than Peers by 3.25

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
9.48
7.17
19.25
-8.36
30.20
Peer Median
6.24
7.17
10.56
12.63
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

29.64

Higher than Peers by 29.70

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
29.64
15.93
142.54
-52.67
23.57
Peer Median
-0.06
12.05
6.17
-2.90
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

26.81

Higher than Peers by 19.23

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
26.81
22.14
149.82
-61.96
4.73
Peer Median
7.58
22.15
27.97
-14.10
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

51.75

Higher than Peers by 49.57

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
51.75
14.50
148.62
-64.44
-1.40
Peer Median
2.18
8.80
--
-3.68
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
--
36.47
12.53
36.32
44.96
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

0.11

Higher than Peers by 0.09

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
0.11
0.07
0.03
0.03
0.03
Peer Median
0.02
0.03
0.05
0.14
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
--
0.04
0.03
0.03
0.03
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.37

Lower than Peers by 0.07

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
2.37
2.32
2.21
2.35
1.61
Peer Median
2.45
2.20
1.93
1.82
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.82

Higher than Peers by 0.10

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
1.82
1.72
1.59
1.64
1.00
Peer Median
1.72
1.72
1.59
1.30
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

11.39

Higher than Peers by 1.68

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
11.39
19.59
37.50
29.15
53.22
Peer Median
9.71
12.28
12.45
16.98
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

17.08

Lower than Peers by 9.84

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
17.08
17.93
19.22
18.57
16.20
Peer Median
26.91
26.23
23.97
24.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.05

Higher than Peers by 0.38

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
1.05
1.18
1.41
1.30
1.60
Peer Median
0.67
0.74
0.88
0.82
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
--
65.45
63.50
66.16
51.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
--
55.26
51.55
64.98
53.23
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
--
107.94
93.67
98.32
86.93
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
--
12.78
21.38
32.82
17.35
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

41.41

Lower than Peers by 13.65

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
41.41
22.21
22.36
33.94
17.20
Peer Median
55.07
39.17
40.74
25.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

4.47

Lower than Peers by 0.02

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
4.47
2.27
2.54
1.74
3.17
Peer Median
4.48
3.61
3.87
2.79
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.19

Higher than Peers by 0.04

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
0.19
0.42
--
--
--
Peer Median
0.15
0.19
0.20
0.65
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

28.85

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
28.85
13.78
12.32
14.96
10.98
Peer Median
--
28.79
25.41
15.07
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

5,820

No difference

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Morepen Lab
5,820
2,622
2,150
1,313
1,749
Peer Median
5,820
3,944
2,959
3,742
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...